HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.78
Day range
$0.75 - $0.79
Year range
$0.59 - $1.93
Market cap
36.37M USD
Avg Volume
7.52M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.72M | — |
Operating expense | 15.35M | -15.32% |
Net income | -13.09M | 25.84% |
Net profit margin | -759.45 | — |
Earnings per share | -0.20 | 68.75% |
EBITDA | -13.25M | 25.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.29M | 23.68% |
Total assets | 71.08M | 16.66% |
Total liabilities | 53.48M | 121.91% |
Total equity | 17.60M | — |
Shares outstanding | 51.77M | — |
Price to book | 2.06 | — |
Return on assets | -46.76% | — |
Return on capital | -123.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -13.09M | 25.84% |
Cash from operations | -14.16M | -5.44% |
Cash from investing | -6.00K | — |
Cash from financing | 8.20M | 601.96% |
Net change in cash | -5.96M | 60.42% |
Free cash flow | -20.32M | -187.34% |
About
Founded
2016
Headquarters
Website
Employees
64
